CoreFirst Bank & Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-8,860
| Closed | -$406K | – | 392 |
|
|
2022
Q1 | $406K | Buy |
8,860
+3,420
| +63% | +$157K | 0.28% | 86 |
|
|
2021
Q4 | $333K | Buy |
5,440
+350
| +7% | +$21.4K | 0.22% | 100 |
|
|
2021
Q3 | $380K | Buy |
5,090
+1,435
| +39% | +$107K | 0.26% | 90 |
|
|
2021
Q2 | $339K | Buy |
3,655
+200
| +6% | +$18.6K | 0.23% | 100 |
|
|
2021
Q1 | $306K | Buy |
+3,455
| New | +$306K | 0.21% | 105 |
|